Article Text
Abstract
In a recent article, Steel, Buchak and Eyal (SBE) argue that current levels of uncertainty do not present a good reason to bar controlled human infection (CHI) trials of COVID-19 vaccines from proceeding. We argue that their argumentation for this conclusion is flawed. SBE are mistaken about the effects which different forms of ignorance have on participants’ ability to provide valid informed consent. Decision-makers considering whether to allow such trials, we argue, must ultimately consider the likelihood that consent to participation in such trials under current conditions would be valid, and whether this likelihood is high enough to permit such trials. This is a question that SBE completely ignore. We conclude that there indeed are valid concerns about conducting CHI trials given the current state of knowledge about COVID-19, concerns which SBE fail to address.
- informed consent
- autonomy
- clinical trials
- research ethics
This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usageStatistics from Altmetric.com
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Exploring the ethics of tuberculosis human challenge models
- Better recognition for research participants: what society should learn from covid-19
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Ethics of research at the intersection of COVID-19 and black lives matter: a call to action
- Uncertainty associated with parents of preterm infants hospitalised in neonatal intensive care unit among selected governmental hospitals in Addis Ababa, Ethiopia, 2022: an institution-based cross-sectional study
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
- Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment